Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Strata Skin SciencesSSKN EV-to-OCF is -3.00 as of Aug. 29, 2026. The stock has 4 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Strata Skin Sciences ranks better than 69.48% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Strata Skin Sciences's Enterprise Value is $8.39 Mil.
Strata Skin Sciences's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $-2.79 Mil. Therefore, Strata Skin Sciences's EV-to-OCF for today is -3.00.
The historical rank and industry rank for Strata Skin Sciences's EV-to-OCF or its related term are showing as below:
SSKN'
s EV-to-OCF Range Over the Past 10 Years
Min: -108.54 Med: 12.35 Max: 116.76
Current: -3
During the past 13 years, the highest EV-to-OCF of Strata Skin Sciences was 116.76. The lowest was -108.54. And the median was 12.35.
SSKN's EV-to-OCF is ranked better than 69.48% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 7.88
vs SSKN: -3.00
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Strata Skin Sciences's PE Ratio (TTM) for today is calculated as:
Strata Skin Sciences's share price for today is $0.005.
Strata Skin Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.410.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Strata Skin Sciences EV-to-OCF Related Terms
Strata Skin Sciences EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Strata Skin Sciences's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Strata Skin Sciences's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strata Skin Sciences EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Strata Skin Sciences's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Strata Skin Sciences's EV-to-OCF falls into.
Strata Skin Sciences's current Enterprise Value is $8.39 Mil.
Strata Skin Sciences's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.79 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Strata Skin Sciences (SSKN) has a EV-to-OCF of -3.00 as of Aug. 29, 2026. According to the industry distribution chart, Strata Skin Sciences ranks #260 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 30.5%.
Is Strata Skin Sciences' EV-to-OCF too high?
Strata Skin Sciences' current EV-to-OCF is -3.00. Based on the distribution chart, Strata Skin Sciences ranks #260 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Strata Skin Sciences' EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Strata Skin Sciences ranks #260 out of 852 companies for EV-to-OCF. This puts Strata Skin Sciences in the upper half of its industry. The industry median EV-to-OCF is 7.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.88, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strata Skin Sciences's current EV-to-OCF is -3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strata Skin Sciences stock overvalued right now?
Based on GuruFocus' analysis, Strata Skin Sciences (SSKN) is currently considered Possible Value Trap. The stock's GF Value™ is $2.00, compared to a current price of $0.01 — trading 99.8% below its estimated fair value. The current EV-to-OCF is -3.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Strata Skin Sciences (SSKN), the current EV-to-OCF is -3.00 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo, and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver, and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSKN has been successfully added to your 
